Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADGM NYSE:CNDA NYSE:DSAQ NASDAQ:IXAQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADGMAdagio Medical$1.40-6.5%$1.29$0.63▼$9.34$23.07M0.11687,976 shs96,592 shsCNDAConcord Acquisition Corp II$11.42$11.31$10.07▼$13.00$105.10M0.0211,021 shsN/ADSAQDirect Selling Acquisition$11.69$11.69$11.00▼$11.80$99.04M-0.0320,971 shsN/AIXAQIX Acquisition$12.10$11.99$10.95▼$11.60$104.01M-0.0112,379 shsN/A(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADGMAdagio Medical-6.53%-19.89%+28.62%+51.86%+140,199,900.00%CNDAConcord Acquisition Corp II0.00%0.00%0.00%+7.63%+8.14%DSAQDirect Selling Acquisition0.00%0.00%0.00%+0.09%+4.75%IXAQIX Acquisition0.00%0.00%0.00%+1.94%+6.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADGMAdagio MedicalN/AN/AN/AN/AN/AN/AN/AN/ACNDAConcord Acquisition Corp IIN/AN/AN/AN/AN/AN/AN/AN/ADSAQDirect Selling AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AIXAQIX AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADGMAdagio Medical 0.00N/AN/AN/ACNDAConcord Acquisition Corp II 0.00N/AN/AN/ADSAQDirect Selling Acquisition 0.00N/AN/AN/AIXAQIX Acquisition 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADGMAdagio Medical$600K35.94N/AN/A$1.31 per share1.07CNDAConcord Acquisition Corp IIN/AN/A$1.06 per share10.78($0.97) per shareN/ADSAQDirect Selling AcquisitionN/AN/AN/AN/A($3.18) per shareN/AIXAQIX AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADGMAdagio Medical-$75.04MN/A0.00∞N/AN/A-274.60%-151.76%N/ACNDAConcord Acquisition Corp II$6.96MN/A0.00∞N/AN/A-31.47%-1.34%8/25/2025 (Estimated)DSAQDirect Selling Acquisition-$270KN/A0.00∞N/AN/AN/A-6.27%N/AIXAQIX AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ALatest ADGM, CNDA, IXAQ, and DSAQ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025N/AADGMAdagio MedicalN/A-$0.51N/A-$0.51N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADGMAdagio MedicalN/AN/AN/AN/AN/ACNDAConcord Acquisition Corp II$0.443.83%N/AN/AN/ADSAQDirect Selling AcquisitionN/AN/AN/AN/AN/AIXAQIX AcquisitionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADGMAdagio Medical1.422.892.51CNDAConcord Acquisition Corp IIN/A0.170.17DSAQDirect Selling AcquisitionN/AN/AN/AIXAQIX AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADGMAdagio Medical48.08%CNDAConcord Acquisition Corp IIN/ADSAQDirect Selling Acquisition47.26%IXAQIX Acquisition27.49%Insider OwnershipCompanyInsider OwnershipADGMAdagio Medical53.45%CNDAConcord Acquisition Corp II0.54%DSAQDirect Selling Acquisition67.90%IXAQIX Acquisition38.43%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADGMAdagio Medical8715.38 million7.16 millionN/ACNDAConcord Acquisition Corp II29.20 million9.15 millionN/ADSAQDirect Selling Acquisition38.47 million4.18 millionNot OptionableIXAQIX AcquisitionN/A8.60 million4.56 millionNot OptionableADGM, CNDA, IXAQ, and DSAQ HeadlinesRecent News About These CompaniesIXAQF IX Acquisition Corp.May 31, 2025 | seekingalpha.comIX Acquisition Delays Yearly Report FilingApril 1, 2025 | tipranks.comIX Acquisition Corp (IXAQ)September 8, 2024 | investing.comIX Acquisition Corp. (IXAQ)August 31, 2024 | finance.yahoo.com(IXAQ) Long Term Investment AnalysisAugust 9, 2024 | news.stocktradersdaily.comNORIX Corporation (IX) Q1 2025 Earnings Call TranscriptAugust 7, 2024 | seekingalpha.comAERKOMM and Nasdaq-Listed IX Acquisition Corp. Announce Merger Agreement and US $35 Million Private PlacementMarch 29, 2024 | globenewswire.comIX Acquisition Corp. Files Definitive Proxy Statement for Shareholder Meeting Seeking Second ExtensionDecember 29, 2023 | finance.yahoo.comIX Acquisition Corp. Announces Increase in Contribution Amount in Connection with its Proposed ExtensionDecember 29, 2023 | finance.yahoo.comIX Acquisition Corp. Announces Shareholder Meeting Results and New Monthly Contribution to be Deposited into Trust AccountDecember 29, 2023 | finance.yahoo.comMedia Sentiment Over TimeADGM, CNDA, IXAQ, and DSAQ Company DescriptionsAdagio Medical NASDAQ:ADGM$1.40 -0.10 (-6.53%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$1.49 +0.09 (+6.28%) As of 07/15/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.Concord Acquisition Corp II NYSE:CNDA$11.42 0.00 (0.00%) As of 07/14/2025Concord Acquisition Corp II does not have significant operations. It focuses on effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.Direct Selling Acquisition NYSE:DSAQ$11.69 0.00 (0.00%) As of 07/14/2025Direct Selling Acquisition Corp. does not have significant operations. The company intends to effect a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring companies in the direct selling industry. The company was incorporated in 2021 and is based in Plano, Texas.IX Acquisition NASDAQ:IXAQIX Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on companies in the technology, media and telecommunications, and information and communication technology industries. The company was incorporated in 2021 and is based in London, United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Delta Air Lines Stock Rallies on New Guidance—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
